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Summary
The assembly of primary cilia is dependant on intrafla-
gellar transport (IFT), which mediates the bidirectional
movement of proteins between the base and tip of the
cilium. In mice, congenic mutations disrupting genes
required for IFT (e.g., Tg737 or the IFT kinesin Kif3a)
are embryonic lethal, whereas kidney-specific disrup-
tion of IFT results in severe, rapidly progressing cystic
pathology [1–3]. Although the function of primary cilia
in most tissues is unknown, in the kidney they are
mechanosenstive organelles that detect fluid flow
through the tubule lumen [4]. The loss of this flow-
induced signaling pathway is thought to be a major
contributing factor to cyst formation [5–7]. Recent
data also suggest that there is a connection between
ciliary dysfunction and obesity as evidenced by the
discovery that proteins associated with human obe-
sity syndromes such as Alstro¨m and Bardet-Biedl
localize to this organelle [8]. To more directly assess
the importance of cilia in postnatal life, we utilized
conditional alleles of two ciliogenic genes (Tg737
and Kif3a) to systemically induce cilia loss in adults.
Surprisingly, the cystic kidney pathology in these
mutants is dependent on the time at which cilia loss
was induced, suggesting that cyst formation is not
simply caused by impaired mechanosensation. In
addition to the cystic pathology, the conditional cilia
mutant mice become obese, are hyperphagic, and
have elevated levels of serum insulin, glucose, and
leptin. We further defined where in the body cilia are
required for normal energy homeostasis by disrupting
cilia on neurons throughout the central nervous sys-
tem and on pro-opiomelanocortin-expressing cells in
the hypothalamus, both of which resulted in obesity.
These data establish that neuronal cilia function in
a pathway regulating satiety responses.
Results
Our understanding of ciliary function in adults is
hindered by the midgestation lethality of intraflagellar
transport (IFT) mutants and severe near-systemic
pathology leading to early mortality in hypomorphic
*Correspondence: byoder@uab.edumutants [3, 9, 10]. To overcome this limitation, we uti-
lized conditional null alleles of Kif3a and Tg737 to sys-
temically disrupt IFT by using a tamoxifen-inducible
Cre recombinase expressed from the actin promoter
(CAGG-creER [2, 11, 12]). The efficient deletion of
Tg737 and Kif3a and subsequent loss of cilia was con-
firmed by western blot and immunofluorescence (Fig-
ures 1A and B). Despite the absence of cilia, the mutants
did not exhibit cystic kidneys, hydrocephalus, or the
ductal abnormalities in the pancreas or liver at 16 weeks
after tamoxifen injection (Figures 1C–1E, ad libitum fed).
These phenotypes are normally present in the Tg737orpk
hypomorphic mutants, in which cilia function is impaired
from conceptus [13–15]. Although there were no overt
biliary duct phenotypes, there was a liver pathology
that was evident in ad libitum-fed mutants at 16 weeks
after injection, and this pathology consisted of an in-
crease in lipid content, as shown by oil red O staining
(Figure 1D and see below). This phenotype is not seen
in the liver of the Tg737orpk mutants. Cysts in the kidney
and liver did eventually form in the conditional mutants.
In the kidney, small cysts first became evident approxi-
mately six months after injection (Figure 1F). By one
year, these cysts were severe and the kidneys had
become markedly enlarged (Figure 1G). In contrast to
the slow rate of cyst progression in the adult-induced
mutants, the administration of tamoxifen to pregnant
females at E17.5 caused rapid cyst development in the
kidney during the perinatal period normally within
2 weeks of birth (Figure 1H).
Although significant cystic pathologies in the kidney
and liver were not seen in adult-induced cilia mutants
until 6 months after tamoxifen administration, both
male and female adult Kif3a and Tg737 conditional
mutants exhibit an increase in body weight shortly after
tamoxifen administration (Figures 2A–2D). In Kif3a and
Tg737 male and female mutants, the weekly food intake
was markedly increased compared to control mice
(Figures 2E–2F, Figures S1A–S1B in the Supplemental
Data available online). The weight gain in these mutants
was primarily due to hyperphagia, as evidenced by the
data from pair-feeding studies. Although Kif3aloxP/null;
CAGG-creER (hereafter called Kif3a-cKO) mice fed ad
libitum gained substantial weight, Kif3a-cKO mice pair
fed to the control (Kif3aloxP/wt; CAGG-creER, hereafter
called Kif3a-cWT) did not exhibit a significant increase
in weight compared to controls (Figure 2G, Figure S1C).
In addition, we diet restricted Kif3a-cKO males to 4.0 g
food/day, similar to the food consumption by control
littermates over a similar period and age. These mutants
did not have significant changes in body weight com-
pared to control littermates during the 8 weeks of diet
restriction; however, the release of this diet restriction
resulted in a rapid weight increase (Figure 2H).
Dual-energy X-ray absorptiometry (DXA) analysis of
mice 14–16 weeks after tamoxifen administration indi-
cated that both Kif3a-cKO males and females had signif-
icant increases in fat mass and percentage fat when fed
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1587Figure 1. Systemic Conditional Deletion of Kif3a and Tg737 in Adult Mice Leads to the Development of Slow-Onset Cystic Kidney Disease
(A) Western-blot analysis of KIF3A protein in kidney, pancreas, and brain in Kif3aloxP/wt; CAGG-creER (W) and Kif3aloxP/null; CAGG-creER (M)
animals 16 weeks after tamoxifen administration (top panel). TG737 protein expression (middle) was used as a loading control. TG737 protein
expression was also measured in Tg737loxP; CAGG-creERTM mutant (M) and control (W) kidney, pancreas, and brain (bottom panel).
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pair-fed mutants (Figure 3A, Figure S1D). Postmortem
carcass analysis indicates that this gain in fat mass in
ad libitum-fed mutants was observed across all fat
pads examined (Figure 3B, Figure S1E). Increased lean
mass was also detected in Kif3a-cKO female mice
(Figure S1D); however, these changes were not seen
after pair feeding.
The ‘‘systemic’’ loss of cilia in Kif3aloxP/null and
Tg737loxP/null mutants fed ad libitum also resulted in
elevated levels of leptin, as well as elevated fasting
serum glucose and insulin, similar to type II diabetes
(Figures 3C–3E and Figures S2A–S2C). Levels of these
hormones as well as fasting glucose were not elevated
in pair-fed mutants, indicating that the phenotype is
a consequence of the obesity rather than a direct effect
of cilia dysfunction.
In addition to increased adiposity, there were changes
in organ weights in Kif3a-cKO mice after tamoxifen
administration (Table 1). In ad libitum-fed mutants
(16 weeks after tamoxifen injection), the livers and kid-
neys were nearly double the weight of controls. This
was not seen in any of the pair-fed mice, indicating that
these phenotypes are a secondary consequence of the
obesity and not due directly to the loss of cilia. The in-
crease in liver weight in the ad libitum-fed mutants was
associated with lipid accumulation, as reveled by oil
red O staining (hepatic steatosis, Figure 1D, Figures
S2E–S2F). Histological analysis indicates that the in-
creased kidney weight at 16 weeks after injection in the
obese mice was not due to the increased cystogenesis
specifically in the ad libitum-fed Kif3a-cKO mutants.
The hyperphagia-induced obesity observed after
tamoxifen administration in adult mice raised the possi-
bility the abnormal feeding behavior might be due to the
loss of ciliary function on neurons. To test this hypothe-
sis, we crossed the conditional cilia mutants with the
synapsin1-cre (Syn1-cre) mice. Although it did not occur
as rapidly as seen for the CAGG-CreERTM line, both
male and female cilia mutants generated with Syn1-cre
become obese (Figure 4). The cause of the delayed phe-
notype relative to what is seen in the CAGG-CreERTM-
induced mutants is uncertain but might reflect differ-
ences in the efficacy of theSyn1-Cre or possibly indicate
additional roles for cilia in energy homeostasis outside
of the central nervous system (CNS).
To further define on which neurons cilia function is
needed, we disrupted cilia on pro-opiomelanocortin
(POMC)-expressing cells in the hypothalamus. We
accomplished this by crossing the Kif3a conditionalmutant with thePOMC-cre deletor line [16, 17]. To deter-
mine whether cilia were present on POMC neurons, we
first crossed the Kif3a flox allele onto the cre reporter
strain Z/EG. These mice were used for the generation of
the conditional mutant and control mice. Cilia were
detected by immunofluorescence analysis with an anti-
body to monoglycylated tubulin [18] and the POMC
neurons by GFP expression. The data confirm that there
is a single cilium present on most if not all POMC
neurons (green fluorescent protein [GFP] positive) as
well as most other cells in the hypothalamus
(Figure 5A). In contrast, cilia were largely absent from
the GFP-positive POMC neurons in the conditional
mutants, whereas non-GFP-positive cell types in the
hypothalamus retain a cilium (Figure 5B). Cilia were
also retained in other regions of the brain outside of
the hypothalamus in these mutants (data not shown)
where POMC-cre is not expressed. Importantly, both
male and female Kif3aloxP/null; POMC-cre (hereafter
called Kif3a-pomcKO) mice exhibited a significant
increase in weight compared to their sex- and age-
matched controls (Figure 5C). As seen for the CAGG-
CreERTM or Syn1-cre line, the obesity was due primarily
to hyperphagia (Figure 5D and data not shown). In addi-
tion, the level of hyperphagia and obesity in the POMC-
cre mice was not as remarkable as seen in the CAGG-
creER mice. It is unlikely that the phenotype is caused
by a loss of POMC neurons because we could detect
no overt changes in the number of GFP-positive cells
in the hypothalamus of the mutants on the Z/EG reporter
background (Figures 5A and 5B). Another possible
mechanism that could cause the obesity phenotype
would be a change in activity. However, our analysis of
the day-night movement patterns of male and female
Kif3a-pomcKO mutants revealed no overt differences
from that in controls (Figures S3A–S3B).
As seen with the CAGG-CreER line, DXA analysis
revealed that the Kif3a-pomcKO mutants had a signifi-
cant increase in percentage body fat and an increase
in lean mass (Figure 5E). The increase in lean mass is
likely to be a secondary effect of the increased adiposity
or due to a small increase in linear growth (Figure 5F).
Kif3a-pomcKO mice also had elevated levels of serum
leptin and insulin and slightly higher blood glucose (Fig-
ures 5G–5I). Oil red O staining again revealed hepatic
steatosis. As seen with the conditional mutants gener-
ated with the CAGG-CreERTM line, the hepatic steatosis
is a secondary effect of the obesity because this pheno-
type is not seen in pair-fed mutants, and POMC-cre is
not expressed in the liver (Figures S3E–S3F).(B) Confocal immunofluorescence analysis of Tg737-cWT and cKO tissues demonstrates the loss of cilia in the pancreatic islet (left panels; 633;
Tg737-cWT above, Tg737-cKO below) and in the nephrons of the kidney (right; 1003; Tg737-cWT above, Tg737-cKO below). The islet and tubule
are roughly outlined in white. The longer green staining pattern (pointed at by tip of a white arrowhead) is due to the background of the secondary
antibody, which reacts with an antigen on the vasculature and is unrelated to cilia.
(C–E) Hematoxylin and Eosin (H&E) staining of Tg737-cWT (top) and Tg737-cKO (bottom) kidney (C), liver ([D], left panels), and pancreas (E) at 16
weeks after tamoxifen administration in ad libitum-fed mice shows no cystic pathology or bile, and pancreatic-duct-related pathologies typical of
the hypomorphic mutants at this age. Oil red O staining ([D], right panels) shows an increase in lipid (red stain) accumulation in the mutants.
(F) H&E staining of Tg737-cWT (top) and Tg737-cKO (bottom) kidneys at 24 weeks after tamoxifen injection in ad libitum-fed mice revealed the
development of cysts in Tg737-cKO mice (bottom).
(G) Trichrome staining of Tg737-cWT (top) and Tg737-cKO (bottom) kidney sections 16 months after tamoxifen administration in ad libitum-fed
mice reveals the presence of very large cystic lesions throughout the kidney of the conditional mutants. The gross appearance of age- and
sex-matched kidneys from Tg737-cWT (top) and Tg737-cKO (bottom) are shown in the right panel.
(H) H&E Staining of Tg737-cWT (top) and Tg737-cKO (bottom) kidney sections 4 weeks after the administration of tamoxifen to the pregnant
mother at embryonic day 18.5.
Pathology in Adult-Induced Cilia Mutants
1589Figure 2. Systemic Loss of Kif3a and/or Tg737 from Adult Mice Results in a Hyperphagia-Induced Obesity Phenotype
(A) Images of Kif3a-cKO (left) and Kif3a-cWT (right) females 16 weeks after administration of tamoxifen. These littermates were of equivalent
weight at time of injection.
(B) Tg737-cKO (left) and Tg737-cWT (right) females are also shown 16 weeks after tamoxifen administration.
(C and D) Body-weight analysis of Kif3a-cWT and Kif3a-cKO (C) and Tg737-cWT and Tg737-cKO (D) males and females after the tamoxifen
administration (week 0). The number of Kif3a-cKO and Kif3a-cWT females analyzed in this study changed at week 6, when several of the
mice were used to evaluate fat pad and organ weight masses. Animals were 8–12 weeks of age at the time of the initial tamoxifen administration.
(E and F) Weekly food intake analysis of Kif3a-cKO and Kif3a-cWT males (E) and Tg737-cKO and Tg737-cWT (F) males after the initial tamoxifen
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1590administration (week 0). Several animals were euthanized in the course of the experiment for body-composition and histological analyses.
Kif3a-cWT controls that were not induced with tamoxifen are also shown in blue (E).
(G) Body-weight analysis in pair-feeding studies of Kif3a-cKO males after the administration of tamoxifen. Separate groups of Kif3a-cWT males
were tested with or without tamoxifen so that changes due to tamoxifen administration could be assessed.
(H) Kif3a-cWT and Kif3a-cKO males were administered tamoxifen and were diet restricted to 4.0 g/day for 8 subsequent weeks. At 8 weeks, all
mice were then fed ad libitum.
‘‘*’’ indicates p % 0.05 and shows the initial point of significant deviation between controls and mutants. Error bars indicate the standard
deviation (SD).
Figure 3. Body Composition and Serum Analysis of the Obesity Phenotype Displayed in Kif3a-cKO Males
(A) Dual energy X-ray absorptiometry (DXA) displaying lean mass, fat mass, and percentage body fat of male Kif3a-cWT and Kif3a-cKO mice 14
weeks after the initial tamoxifen administration. Body weight was measured immediately after the DXA.
(B) Carcass analysis of various fat pads and brown fat in Kif3a-cWT and Kif3a-cKO males 16 weeks after the initial tamoxifen administration.
(C) Box and whisker plot of nonfasting serum leptin levels in Kif3a-cWT and KO males 16 weeks after the initial tamoxifen administration. Eight
out of then Kif3a-cKO ad libitum-fed mice were above the maximum threshold of detection (40 ng/ml) and were assigned a value of 40 ng/ml.
Mean serum leptin levels are indicated by purple stars.
(D) Serum glucose analysis of Kif3a-cWT and Kif3a-cKO males measured after 4 hr of fasting conditions.
(E) Box and whisker plot of nonfasting serum insulin analysis of Kif3a-cWT and Kif3a-cKO males. Four out of 15 Kif3a-cKO males reached the
highest detectable threshold for serum insulin analysis and were assigned the value of 8.0 ng/ml for statistical analysis.
(F) Serum corticosterone analysis shows no significant differences between Kif3a-cWT and Kif3a-cKO males.
‘‘*’’ indicates p% 0.05 in (C) and (E); the means are indicated by purple stars. Error bars indicate the SD.
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(no tamoxifen, n = 4)
Kif3a loxP/WT
CAGG-CreER Females
(tamoxifen, n = 4)
Kif3a loxP/null
CAGG-CreER Females
(tamoxifen, n = 4)
Kif3a loxP/null
CAGG-CreER Females
(tamoxifen, n = 4)
Liver 1.266 6 0.067 1.319 6 0.067 2.424 6 0.295a 1.275 6 0.143
Kidney 0.292 6 0.017 0.300 6 0.016 0.730 6 0.295a 0.325 6 0.018
Pancreas 0.152 6 0.005 0.151 6 0.017 0.187 6 0.011 0.146 6 0.020
Heart 0.132 6 0.006 0.142 6 0.008 0.167 6 0.008a 0.116 6 0.007a
Ovary 0.011 6 0.001 0.013 6 0.001 0.014 6 0.001 0.014 6 0.002
Lung 0.213 6 0.025 0.227 6 0.011 0.257 6 0.033 0.196 6 0.024
a Organ weight significantly different compared to controls (p < 0.05).Discussion
Cilia function is thought to be required for normal renal
physiology, as evidenced by the fact that the disruption
of cilia specifically in the developing kidney results in
severe cystic disease [1, 19]. Renal cilia have been
shown to function as mechanosensors that detect fluid
movement through the lumen of the nephron, and the
loss of this mechanosensory activity is thought to be
a key factor leading to cystogenesis [5–7]. Thus, it was
surprising that the rate of cyst formation was so attenu-
ated after cilia were ablated in the adult mice compared
to what occurs in the perinatal period. The difference in
the cystic phenotype is not due to limited cre activity
because immunofluorescence and western-blot analy-
sis demonstrate a dramatic loss of cilia on renal tubules
along with a reduction in KIF3A and TG737 protein levels
well before the cystic pathology develops. The cause of
the switch from a very aggressive cystic disorder in cilia
mutants induced during renal development to a mech-
anism of slow cyst formation in adult is still being
assessed. It remains a formal possibility that the large
kidney cysts that develop in the adult induced mutants
at 16 months after tamoxifen injection are related to
the severity of obesity, as is the case for the hepatic
steatosis and glucose homeostasis abnormalities. We
are currently addressing this issue by using a kidney-
specific tamoxifen-inducible Cre line. Overall, we be-
lieve the data indicate that renal cyst formation, as is
likely the case for the pancreatic and hepatic ductile
abnormalities associated with the cilia mutants such
as Tg737orpk [13, 14, 20], requires more than just the
loss of a pathway regulated by cilia-mediated mechano-
sensation.
In addition, our data show that the loss of cilia in adult
mice alters their feeding behavior and results in obesity
with a phenotype resembling insulin resistance and
diabetes. Obese mutants also exhibit renal hypertrophy,
which is seen in diabetic mouse models and human
patients [21, 22]. We further demonstrate that the
obesity phenotype can largely be recapitulated by the
deletion of cilia on neurons throughout the CNS and,
more specifically, on POMC-expressing cells. Although
POMC-cre is also expressed in the pituitary, it is likely
that the phenotype is due to the loss of cilia function in
hypothalamic POMC neurons. This is based on the
fact that an obesity phenotype is also seen in cilia
mutants generated with the SynI-cre line [23]. Further-
more, we analyzed corticosterone levels in obese andpair-fed mutants that would probably be associated
with affects on the pituitary and detected no significant
differences or correlations between obese and nonob-
ese mutant or control mice (Figure 3F and Figures S3D
and S4G). Together, these data argue against cilia dys-
function on cells in the anterior pituitary as being the
cause of the obesity.
Another interesting observation is that the phenotype
of the cilia mutants generated with the POMC- or SynI-
cre lines are not as severe as that seen when cilia loss
is induced systemically in adults. This could reflect a dif-
ference in the efficacy or time of expression of these cre
lines or the possibility that cilia have additional roles in
energy balance outside of the CNS. Another possibility
is that neuronal feeding circuits are able to compensate
for the congenic loss of cilia function during develop-
ment but lack this capacity in adults after the disruption
of cilia.
Mutations in several cilia- or basal-body-localized
proteins have been implicated in rare human obesity
syndromes such as Alstro¨m (ALMS) and Bardet-Biedl
(BBS) [8, 24]. There are multiple proteins involved in
BBS, and recent data indicate that they function as
Figure 4. Conditional Disruption of Tg737 in Neurons
Body weights of Tg737-Syn1KO and Tg737-Syn1WT male and
female mice indicate that the loss of neuronal cilia because of the
disruption of Tg737 results in an obese phenotype. Error bars indi-
cate the standard deviation.
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(A and B) Confocal immunofluorescence analysis of Kif3aloxP/wt (Kif3a-pomcWT) (A) and Kif3aloxP/null (Kif3a-pomcKO) (B) arcuate nucleus (1003)
bred onto the Z/EG Cre reporter line in the presence of the POMC-cre deletor strain demonstrates the loss or stunting of neuronal cilia (red) on
affected POMC neurons (green). Inserts show cilia (red) without the GFP signal and are derived from the boxed region in the image. Note that cilia
are still retained on the non-POMC-expressing cells in the hypothalamus.
(C) Body-weight analysis of Kif3a-pomcKO and Kif3a-pomcWT males and females.
(D) The weekly food intake of Kif3a-pomcKO females was consistently increased from that of the Kif3a-pomcWT controls.
(E) DXA analysis performed on adult (age 22–25 weeks) mice showed significant increases in fat mass and percentage fat in both sexes and lean
mass in male Kif3a-pomcKO mice. Body weight was measured after the DXA analysis.
(F) Nose-to-anal length analysis conducted in anesthetized adult (age 22–25 weeks) Kif3a-pomcWT and Kif3a-pomcKO mice. The average length
from independently determined two blinded measurements was used.
(G–I) Serum analysis of nonfasted leptin (G), 4 hr fasted glucose (H), and nonfasted insulin (I) in Kif3a-pomcWT and Kif3a-pomcKO mice.
‘‘*’’ indicates p% 0.05 in (C) and (D) and shows the initial point of significant deviation between controls and mutants. The purple stars in (G) and (I)
represent the means of the individual groups. Error bars indicate the SD.a complex to regulate vesicular transport to the cilium
[24]. The ALMS1 protein, which is involved in human
Alstro¨m syndrome, is also located at the base of the
cilium, and the disruption of ALMS1 caused the trunca-
tion of the cilium [22]. Recently, another gene involved in
the obesity and skeletal defects observed in human
patients with Carpenter Syndrome was identified as
Rab23 [25]. RAB23 is a negative regulator of the hedge-
hog pathway that functions downstream of the hedge-
hog receptors Smoothened and Patched, as well as cilia
and/or IFT proteins such as TG737 (IFT88). Although thepathway disrupted in Carpenter Syndrome patients or in
which the tissue loss of RAB23 leads to the obesity phe-
notype is unknown, these recent data raise the possibil-
ity that the increased adiposity in our conditional cilia
mutants might be related to abnormalities in hedgehog
signaling. Overall, these data are supportive of a role
for the ciliary and/or basal body in regulating feeding
behavior. The control of feeding in mammals is complex
and involves signals from diverse tissues, such as the
intestine, pancreas, adipose, and stomach [26, 27]. In
many cases, these signals converge on the CNS and
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are consistent with a role for cilia on the hypothalamic
POMC neurons in the reception or response to a satiety
signal such as leptin or insulin, and suggest that this
might be disrupted in the BBS or ALMS patients. An
alternative possibility is that cilia are involved in a path-
way connecting POMC neuronal projections to known
reward circuitry in regions of the brain such as the ven-
tral tegmental area, as recently proposed for leptin and
its receptor [27, 28]. As such, our data provide a more
comprehensive assessment of the cellular mechanisms
controlling food intake in mammals and could provide
novel insights into one of the central satiety pathways
in humans.
Supplemental Data
Experimental Procedures and three figures are available at http://
www.current-biology.com/cgi/content/full/17/18/1586/DC1/.
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